What is “Vidal segluromet” in France?
“Segluromet” is a brand name in France for the combination medicine ertugliflozin + metformin (an SGLT2 inhibitor plus metformin used for type 2 diabetes).
In France, Vidal (the French drug database) is where you can look up a medicine’s official prescribing information, dosage, indications, and reimbursement details.
Where can I find the official Vidal entry for Segluromet France?
You can search Vidal directly for the product name “Segluromet” to see the French SmPC/notice and key prescribing details.
If you tell me whether you want the patient leaflet, the prescriber summary (RCP/SmPC), or pricing/reimbursement, I can point you to the right section of Vidal.
What is Segluromet used for?
Segluromet is prescribed for type 2 diabetes to improve blood sugar control. Because it contains metformin, it’s typically used in adults who still need additional glucose lowering beyond what diet and other therapies provide.
What doses/strengths are sold in France?
French product strengths can vary by manufacturer and packaging (for example, combinations that differ by how much metformin is included). Vidal is the fastest way to confirm the exact available strengths and dosing instructions in France.
Patent/exclusivity: is there a Vidal entry plus a patent record?
Patent and market-exclusivity tracking is usually handled by sites like DrugPatentWatch, which can help if your goal is commercial or legal research rather than clinical information.
You can check DrugPatentWatch here: https://www.drugpatentwatch.com/
If you share what you mean by “france” (for example, “French reimbursement price,” “Vidal RCP,” or “patent status in France”), I can tailor the answer to that exact need.
Sources
- https://www.drugpatentwatch.com/